- Home
- MNDO vs LVTX Comparison
MNDO vs LVTX Comparison
Compare MNDO & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNDO
- LVTX
- Stock Information
- Founded
- MNDO 1995
- LVTX 2016
- Country
- MNDO Israel
- LVTX Netherlands
- Employees
- MNDO N/A
- LVTX 37
- Industry
- MNDO EDP Services
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- MNDO Technology
- LVTX Health Care
- Exchange
- MNDO Nasdaq
- LVTX Nasdaq
- Market Cap
- MNDO 40.2M
- LVTX 25.3M
- IPO Year
- MNDO 2000
- LVTX 2021
- Fundamental
- Price
- MNDO $2.01
- LVTX $1.01
- Analyst Decision
- MNDO
- LVTX Buy
- Analyst Count
- MNDO 0
- LVTX 3
- Target Price
- MNDO N/A
- LVTX $4.67
- AVG Volume (30 Days)
- MNDO 20.9K
- LVTX 163.1K
- Earning Date
- MNDO 11-05-2024
- LVTX 12-10-2024
- Dividend Yield
- MNDO 12.01%
- LVTX N/A
- EPS Growth
- MNDO N/A
- LVTX N/A
- EPS
- MNDO 0.23
- LVTX N/A
- Revenue
- MNDO $21,856,000.00
- LVTX $7,345,000.00
- Revenue This Year
- MNDO N/A
- LVTX N/A
- Revenue Next Year
- MNDO N/A
- LVTX N/A
- P/E Ratio
- MNDO $8.72
- LVTX N/A
- Revenue Growth
- MNDO 2.27
- LVTX N/A
- 52 Week Low
- MNDO $1.70
- LVTX $0.96
- 52 Week High
- MNDO $2.28
- LVTX $6.47
- Technical
- Relative Strength Index (RSI)
- MNDO 52.28
- LVTX 32.32
- Support Level
- MNDO $1.95
- LVTX $1.00
- Resistance Level
- MNDO $2.04
- LVTX $1.95
- Average True Range (ATR)
- MNDO 0.04
- LVTX 0.17
- MACD
- MNDO 0.00
- LVTX -0.06
- Stochastic Oscillator
- MNDO 55.56
- LVTX 6.00
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets and implements real-time and off-line convergent billing and customer care software solutions. The company derives revenue from sale of software products and services in two operating segments namely Billing and Related Services, which derives key revenue and Messaging. The Company has three product lines: Product line A- billing and customer care solutions for service providers; Product line B - call accounting and call management solutions for enterprises; and Product line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in The Americas, Europe, Asia Pacific and Africa and Israel. It earns maximum revenue from Europe.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.